EDGAR Filing Documents for 0001144204-12-012714

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001144204-12-012714

Filing Date

2012-03-02

Accepted

2012-03-02 16:30:43

Documents

Period of Report

2011-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-K	v302731_10k.htm	10-K	1119263
2	EXHIBIT 10.20	v302731_ex10-20.htm	EX-10.20	52919
3	EXHIBIT 21.1	v302731_ex21-1.htm	EX-21.1	3540
4	EXHIBIT 23.1	v302731_ex23-1.htm	EX-23.1	5409
5	EXHIBIT 31.1	v302731_ex31-1.htm	EX-31.1	9477
6	EXHIBIT 31.2	v302731_ex31-2.htm	EX-31.2	9266
7	EXHIBIT 32.1	v302731_ex32-1.htm	EX-32.1	3542
8	EXHIBIT 32.2	v302731_ex32-2.htm	EX-32.2	3510
9	GRAPHIC	chart.jpg	GRAPHIC	64948
	Complete submission text file	0001144204-12-012714.txt		3908274

Data Files

Seq	Description	Document	Type	Size
10	XBRL INSTANCE DOCUMENT	kerx-20111231.xml	EX-101.INS	486544
11	XBRL TAXONOMY EXTENSION SCHEMA	kerx-20111231.xsd	EX-101.SCH	18061
12	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	kerx-20111231_cal.xml	EX-101.CAL	44041
13	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	kerx-20111231_def.xml	EX-101.DEF	116568
14	XBRL TAXONOMY EXTENSION LABEL LINKBASE	kerx-20111231_lab.xml	EX-101.LAB	147737
15	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	kerx-20111231_pre.xml	EX-101.PRE	139922

Mailing Address

Business Address 750 LEXINGTON AVENUE . NEW YORK NY 10022 212-531-5965

KERYX BIOPHARMACEUTICALS INC (Filer) CIK: 0001114220 (see all company filings)